ProCE Banner Activity

Establishing HER2-Targeted Therapies in the Treatment of HER2-Low Breast Cancer


Download these slides from a live symposium at ASCO 2023 to learn more about established and emerging targeted therapies for patients with HER2-low breast cancer.

Released: June 02, 2023



Shanu Modi

Shanu Modi, MD

Professor of Medicine
Section Head, HER2 Breast Program
Breast Medicine Service, Department of Medicine
Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College
New York, New York

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.


Daiichi Sankyo

Gilead Sciences, Inc.